Don’t Let Insurers Decide

Act now to protect your Alpha-1 therapy

Prescription Pad

Insurance policy limiting therapy for Alpha-1 ‘playing with our health,’ patient says

One of the country’s largest health insurers, Humana, recently made a policy decision that can adversely affect many people with Alpha-1.

Humana now restricts augmentation therapy for Alpha-1 patients to a single product. The critical therapy is available in four formulations that, as  read more…

Rx pad

Patients urged to contact Humana regarding decision to cover only one Alpha-1 therapy

One of the country’s largest health insurers, Humana, recently made a policy decision that can adversely affect many people with Alpha-1.

Humana now restricts augmentation therapy for Alpha-1 patients to a single product. The critical therapy is available in four formulations  read more…

prescription-pad

Foundation disputes Humana response on ‘dangerous decision’ to limit Alpha-1 therapy

In November, Alpha-1 Foundation President John Walsh and Clinical Director Robert Sandhaus wrote to Humana, challenging the insurer’s new policy to limit augmentation therapy for Alpha-1 patients to only one product, Zemaira.

The Alpha-1 Foundation Medical and Scientific Advisory Committee (MASAC)  read more…

Alpha-1 patients, caregivers react to Humana policy on augmentation choice

From Misha Melehes, of Alta, WY:

My husband has been on augmentation therapy for the last 10 years. He started with Prolastin, when it was the only option, and then moved on to Aralast.  With both of these therapies he experienced  read more…

John Walsh

Alpha-1 Foundation, Association urge Humana to reverse augmentation policy

The Alpha-1 Foundation and Alpha-1 Association are urging health insurer Humana to reverse its “bad policy decision” to cover only one augmentation therapy product for Alpha-1-related lung disease.

Humana is one of the largest health insurers in the United States. Its  read more…

Foundation president responds to Humana on policy restricting augmentation therapy

Alpha-1 Foundation President John Walsh’s response to Humana representatives regarding the insurance company’s policy decision to restrict augmentation therapy choices. Following the letter is the Alpha-1 Foundation Medical and Scientific Advisory Committee (MASAC) refutation of Humana’s reasoning for the policy.

Summary of  read more…

Humana defends decision to limit augmentation therapy coverage

Humana Inc.
323 West Main Street
Center Tower s” Floor
Louisville, KY 40202
www.humana.com

Humana Pharmacy Solutions”

November 26, 2013

Mr. John Walsh
Alpha-l Foundation
3300 Ponce de Leon Blvd
Coral Gables, FL 33134

Re: Summary of Concerns regarding Humana Formulary: List of Covered  read more…